RALLYBIO CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
RALLYBIO CORPORATION (RLYB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 160.31 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-09-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2021-09-09
- RALLYBIO CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-06-30 was 160.31M shares, a 12.37% increase year-over-year.
- RALLYBIO CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-06-30 was 142.67M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2021-06-30 | 160.31M shares 10-Q · filed 2021-09-09 | 160.31M shares 10-Q · filed 2021-09-09 |
| 2020-06-30 | 142.67M shares 10-Q · filed 2021-09-09 | 142.67M shares 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |